Healthy adults
Conditions
Interventions
Take one packet the test food (250 mg/packet) at once a day.
Take two packets the test food (250 mg/packet) at once a day.
Sponsors
IMEQRD Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Age between 30 to 59 years old. 2.Japanese males and females 3.Those who have high BMI. 4.Those who have defecation at least every day. 5.Those who can use smartphones or PC to record a diary. 6.Those who were given sufficient explanations of the trial information, and signed the document of the informed consent with well understanding for the trial objective; also, those who voluntarily joined the trial.
Exclusion criteria
Exclusion criteria: 1.Those who are currently given any medical treatment with drugs or traditional Chinese medications. 2.Those who have medical treatments such a diet therapy and/or an exercise therapy. 3.Those who had been experiencing a severe disease. 4.Those who have currently been taking yogurts, Lactobacillus containing beverages, or Lactobacillus containing foods and supplements, which have health claims, for being healthy. However, those who can discontinue taking these foods during the trial period after obtaining informed consent will be allowed to join the trial. 5.Those who have currently been taking drugs, quasi-drug products, or foods and supplements which have health claims for promoting metabolism, improving fatigue and stress, and reducing blood pressure. However, those who can discontinue taking these materials during the trial period after obtaining informed consent will be allowed to join the trial. 6.Those who have a drug allergy or a food allergy, or those who had been experiencing these diseases. 7.Heavy drinkers who drink over 60 g alcohol/day. 8.Those who have a smoking habit (over 21 cigarettes/day). 9.Those who are planning extremely change their lifestyle (such as diet, sleep, or exercise) during the trial period. 10.Those who work on night shift jobs and the shiftwork. 11.Those who are planning travels to foreign countries during the trial period. 12.Those who are currently pregnant or breastfeeding, or those who are planning to pregnant during the trial period. 13.Those who joined other clinical trials from 1 month before obtaining informed consent in this trial, or those who have currently been joined other clinical trials. Also, those who are planning to join other clinical trials. 14.Those who are unsuitable for this trial that judged by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Questionnaire for body weight-related QOL | — |
Secondary
| Measure | Time frame |
|---|---|
| Body mass, waist circumference, blood pressure, total cholesterol, HDL, LDL, triglycerides, insulin, fasting blood glucose, gut microbiota (16S rRNA-seq), free fatty acids | — |
Countries
Japan
Contacts
Public ContactHirokuni Kayama
IMEQRD Co., Ltd. Planning and Sales Department
Outcome results
None listed